Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Regulation changes allow more pharmacist-administered vaccines
Two east coast states have made recent vaccine legislation updates, expanding community access through barrier removal.
Everything you need to know about the take home naloxone program
The Take Home Naloxone Pilot saved three lives every day. From Friday, free naloxone will be accessible to all Australians in need.
Giving back to rural pharmacy
NSW Pharmacist of the Year, founder of PharmOnline and university lecturer – Anna Barwick shows why she’s ‘indispensable’ to her rural community.
Active ingredient prescribing mandated
From 1 February 2021, medicines will be prescribed by active ingredient on all Pharmaceutical Benefits Scheme (PBS) prescriptions.
Are you prepared for the huge Moderna vaccine demand?
With state barriers now removed and extra stock on the way, the rollout of the Moderna vaccine is set to start with a bang.
Cannabis drug interactions
Pharmacists play a central role in ensuring the quality and safe use of cannabis and cannabis-based products.
